Development of a Multivariate Prognostic Model for Lenvatinib Treatment in Hepatocellular Carcinoma.

Xiaomi LiXiaoyan DingMei LiuJingyan WangWei LiJinglong Chen

Published in: The oncologist (2023)

The MPML stratified patients according to baseline clinical characteristics had a strong performance in predicting Lenvatinib efficacy and has the potential for use as an auxiliary clinical tool for individualized decision-making.

Keyphrases

end stage renal disease
decision making
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
data analysis
climate change
smoking cessation